ASCO24: Another win for Opdivo/Yervoy in first-line HCC despite uncertainties
The prognostic factor(s) driving outcomes at the initial stages of hepatocellular carcinoma remain unclear, complicating the treatment choice.
The prognostic factor(s) driving outcomes at the initial stages of hepatocellular carcinoma remain unclear, complicating the treatment choice.
What's Your Reaction?
